Summary & Key Points
"ANTIBIOCLIC Afrique is a clinical decision-support tool for the management of COVID-19 in West Africa. It is intended for five countries: Côte d’Ivoire, Burkina Faso, Gabon, Mali, and Senegal."
ANTIBIOCLIC Africa is a clinical decision-support tool for managing COVID-19 in West Africa. It is designed for five countries: Côte d’Ivoire, Burkina Faso, Gabon, Mali, and Senegal. The tool aims to help clinicians tailor patient care based on clinical signs, using local guidelines specific to each country. In the long term, ANTIBIOCLIC Africa also seeks to optimize antibiotic prescribing and help combat antibiotic resistance in West Africa, a major global health challenge.
On Saturday, November 26, 2022, a meeting was held at the National Institute for Training Health Workers (INFAS) with resident physicians from Côte d’Ivoire’s hospitals as part of the ANTIBIOCLIC-AFRIQUE project activities to disseminate the Antibioclic Afrique tool.
The meeting began with training on antibiotic therapy, followed by a presentation of the Antibioclic Afrique tool: Antibioclic Afrique: Rational antibiotic therapy in primary care (antibioclic-afrique.com).
Participants highly appreciated the meeting.
